Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorized
  2. c-icon icon-chevron-right
October 19, 2020

How rising unemployment rates point to slow US recovery – Why obesity has made Covid-19 worse in the US

By Paul Dennis

19 October

Experts and economists initially forecast the US economy to recover by the end of the year. The growth posted in the second quarter was also encouraging.

However, the slowdown in the third quarter raises questions about the forecasted recovery.

Prof. Steve Hanke, economist at Johns Hopkins University, questioned the predicted V-shaped recovery, and shared an article on how the number of unemployment claims increased to the highest levels last week since August.

The four-week average of the claims increased to more than 860,000, indicating that a greater number of people are losing their jobs.

Further, several companies have announced layoffs pointing towards a slower than expected economic recovery.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

According to a survey conducted by the Wall Street Journal, more than half of experts and economists surveyed noted that they did not expect the labour market to return to pre-pandemic levels until 2023.

The results of the survey indicate a slower recovery than that predicted six months ago.

Meanwhile, economist Celestine Chukumba noted that the US was already an unhealthy nation before the arrival of the Covid-19 disease due to its obesity rates, and that this was a factor in the US having the highest number of Covid-19 cases in the world.

Read more

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU